2.08
2.08 (-1.36%)
As of Jun 14, 2022
Renovorx, Inc. [RNXT]
Source:
Company Overview
RenovoRxis a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. Our mission is tolead a revolution in oncology therapy by delivering its innovative and targeted intra-arterial (IA) delivery of chemotherapydirectly to solid tumors.
Country | United States |
Headquarters | san jose, california |
Phone Number | 408-800-2649 |
Industry | |
CEO | Shaun R. Bagai |
Website | www.renovorx.com |